Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis
New pharmacologic advances in the treatment of diabetes include SGLT-2 inhibitors, which have been demonstrated in randomized-controlled clinical trials to reduce overall and cardiac-specific mortality and slow progression of chronic kidney disease. Euglycemic diabetic ketoacidosis is a rare but lif...
Guardado en:
Autores principales: | Clara M. Gomez-Sanchez, MD, Bian X. Wu, MD, Jeffrey E. Gotts, MD, Robert W. Chang, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3006de9df1f84acda593c0de6bbb7600 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Second line therapy in type 2 diabetes: legacy effect activation
por: Ekaterina A. Shestakova
Publicado: (2017) -
Acidosis renal y diabetes insípida
por: SILVA,GABRIEL
Publicado: (1956) -
Encefalomiopatia mitocondrial, acidosis lactica y apariencia de accidentes vasculares cerebrales
por: Mesa L,Tomas, et al.
Publicado: (1990) -
Ruminal acidosis: strategies for its control
por: Jaramillo-López,Esaúl, et al.
Publicado: (2017) -
Acidosis tubular renal: Presentación de 2 casos clínicos
por: OCHOA,EDECIA, et al.
Publicado: (1975)